Welcome to our dedicated page for Camtek SEC filings (Ticker: CAMT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Semiconductor tools mean dense disclosures. Camtek’s 10-K spans intricate discussions on wafer-level metrology, export controls and customer concentration—details investors can’t afford to miss. Yet combing through hundreds of pages to understand revenue tied to advanced packaging or to track when executives sell stock is time-consuming.
Stock Titan solves that problem. Our AI reads every Camtek SEC filings explained simply, surfaces the metrics that move the share price, and delivers real-time alerts the moment a Camtek Form 4 insider transactions real-time notice hits EDGAR. Whether you’re looking for the next Camtek quarterly earnings report 10-Q filing, an unexpected Camtek 8-K material events explained, or the full Camtek annual report 10-K simplified, you’ll find it here—annotated, summarized and searchable.
Use our platform to:
- Track Camtek insider trading Form 4 transactions and spot buying or selling before material announcements
- Compare margin trends with AI-generated Camtek earnings report filing analysis
- Review Camtek proxy statement executive compensation without wading through boilerplate tables
- Monitor supply-chain risks flagged in 8-K filings
Camtek Ltd. reported record Q3 2025 revenue of $126.0 million, up 12% year over year. GAAP gross profit was $63.0 million (50.0% margin) and non-GAAP gross profit was $64.9 million (51.5%). GAAP operating income reached $31.9 million (25.3% margin), while non-GAAP operating income was $37.6 million (29.9%).
Due to a debt transaction, Camtek recorded an $89 million loss tied to extinguishment of notes, resulting in a GAAP net loss of $53.2 million (−$1.16 per basic share). On a non-GAAP basis, net income was $40.9 million ($0.82 per diluted share), up 10% year over year. The company issued $500 million of 0% convertible senior notes in a private offering and used part of the proceeds to repurchase prior notes; cash, deposits and marketable securities totaled $794.0 million as of September 30, 2025. Management expects Q4 2025 revenue of around $127 million and projects $495 million for 2025, implying 15% growth over 2024.
Camtek Ltd filed a report attaching an indenture dated
The document lists the governing contract for the notes but does not state a principal amount, issuance date, conversion terms, or other economic details in the provided excerpt. The exhibit therefore documents the legal framework for the convertible notes without disclosing transaction size or investor impact in this text.
Camtek Ltd. furnished a Form 6-K reporting a proposed private offering of $400 million of 0.00% convertible senior notes due 2030 to qualified institutional buyers under Rule 144A, disclosed by a press release dated September 11, 2025 (Exhibit 99.1). The company also filed unaudited interim financial statements for the six months ended June 30, 2025 and 2024 (Exhibit 99.2) and an Operating and Financial Review and Prospects (Exhibit 99.3), which are deemed filed under the Securities Act and Exchange Act. The registrant indicated it files annual reports on Form 20-F and did not elect to furnish the information under Rule 12g3-2(b).
Form 144 notice for Camtek Ltd (CAMT) reporting a proposed sale of 4,018 ordinary shares through Oppenheimer & Co. Inc. on or about 08/22/2025 with an aggregate market value of $328,431.32. The filing lists the acquisition history for the securities sold: a mix of performance stock units and restricted stock units acquired on 04/28/2021, 01/24/2022 and 01/16/2023, totaling the reported shares. The filer certifies no undisclosed material adverse information. The notice contains no prior sales in the past three months.
Form 144 notice for Camtek Ltd (CAMT) shows a proposed sale of 8,504 ordinary shares through Oppenheimer & Co. Inc. on or about 08/14/2025 with an aggregate market value of $749,457.52. The filing lists the acquisition details for those shares: a mix of performance share units (PSUs) and restricted stock units granted by the issuer between 04/28/2021 and 01/16/2023, totaling the reported units by grant date and type. The filing states there were no securities sold by the reporting person in the past three months. The filer affirms no undisclosed material adverse information and includes the standard signature statement regarding accuracy.
Wasatch Advisors LP reports beneficial ownership of 3,529,165 ordinary shares of Camtek Ltd, representing 7.7% of the class. The filing shows Wasatch has sole dispositive power over 3,506,727 shares and reports no shared voting or dispositive power. The document contains two different figures for sole voting power in separate sections (2,458,296 and 2,485,296), which are presented as reported and are not reconciled within the filing.
The filing is submitted as a Schedule 13G/A by an investment adviser (Type IA) and includes a certification that the holdings were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.
Camtek Ltd (CAMT) submitted a Form 144 notice reporting a proposed sale of 21,321 ordinary shares through Oppenheimer & Co. Inc., with an aggregate market value of $1,844,906.13. The sale is scheduled approximately for 08/13/2025 and the shares are listed on Nasdaq. The form states the issuer has 45,449,306 shares outstanding, providing context for the transaction size.
The securities to be sold were acquired as restricted stock units from the issuer on 04/28/2021 (2,774 shares), 01/24/2022 (4,637 shares), and 01/16/2023 (13,910 shares), which together equal the 21,321 shares offered. The filing reports no securities sold in the past three months and includes the seller's standard representation that they are unaware of any undisclosed material adverse information; a trading-plan reference is noted but no plan adoption date is provided.
Camtek Ltd (CAMT) Form 144 filing discloses that an unidentified insider intends to sell 7,300 ordinary shares through broker Oppenheimer & Co. The planned transaction, scheduled on or about 08-07-2025, carries an aggregate market value of $594,147, based on the prevailing market price when the notice was prepared.
The shares represent roughly 0.016 % of Camtek’s 45.45 million shares outstanding, implying a modest dilution impact. The stock to be sold derives from previously granted restricted stock units (RSUs) acquired on 09-24-2020 (6,500 shares) and 08-18-2021 (800 shares). No shares were sold by the filer in the past three months, and the signer affirms possession of no undisclosed material adverse information.
While the filing is routine and compliant with Rule 144, it signals a limited insider disposition that investors may interpret as a marginally negative sentiment check rather than a material event for the company’s fundamentals.
FAQ
What is the current stock price of Camtek (CAMT)?
What is the market cap of Camtek (CAMT)?
